It all starts with a patient

Global Liver Institute saves lives by empowering patient advocates to collaborate with policymakers, clinicians, and industry to drive the liver health field forward.

It all starts with a patient

Global Liver Institute saves lives by empowering patient advocates to collaborate with policymakers, clinicians, and industry to drive the liver health field forward.

It all starts with a patient

Global Liver Institute saves lives by empowering patient advocates to collaborate with policymakers, clinicians, and industry to drive the liver health field forward.

It all starts with a patient

Global Liver Institute saves lives by empowering patient advocates to collaborate with policymakers, clinicians, and industry to drive the liver health field forward.

It all starts with a patient

Global Liver Institute saves lives by empowering patient advocates to collaborate with policymakers, clinicians, and industry to drive the liver health field forward.

It all starts with a patient

Global Liver Institute saves lives by empowering patient advocates to collaborate with policymakers, clinicians, and industry to drive the liver health field forward.

It all starts with a patient

Global Liver Institute saves lives by empowering patient advocates to collaborate with policymakers, clinicians, and industry to drive the liver health field forward.

Patient Testimonials

How we’re making a difference.

Katelin Img

Dr. Katelin H.

There is nothing more powerful than sharing your story with others, whether with your own family or with the whole country. You’d be surprised how much impact simple actions can have.

Karen Hoyt

Karen Hoyt

Connecting to others with liver disease is so crucial. It is easy to get caught in a cycle of malnutrition, fatigue, isolation, depression, pain, and on it goes. By reaching out to others, and their caregivers, I aspire to inspire connections from around the globe.
Elena

Elena Covarrubias

As a professional I’ve worked with hundred of people with NASH and detected some others. I know this disease is not known enough by people and by health professionals, even physicians. My duty is to identify those in risk of developing NASH and NAFLD.

About GLI

Improving the lives of individuals & families.

Global Liver Institute (GLI) is a nonprofit organization founded in the belief that liver health must take its place on the global public health agenda commensurate with the prevalence and impact of liver illness.

GLI promotes innovation, encourages collaboration, and supports the scaling of optimal approaches to help eradicate liver diseases. Operating globally, GLI is committed to solving the problems that matter to liver patients and equipping advocates to improve the lives of individuals and families impacted by liver disease.

Global Liver Home3

1.5 Billion

People around the globe are currently living with liver disease1

1 In 4

1 in 4

People are estimated to already have NAFLD or NASH2

Woman Showing Liver

Less than 27%

Of people with liver cancer survive five years after diagnosis, worldwide.3

Gli Live Logo
GLI LIVE

GLI LIVE started in March 2020, as a COVID-19 response program for liver patients. It has now evolved into a weekly educational show with tailored information for patients living with liver diseases on a variety of timely topics.

NutriStyle Logo Transparent Background (1)
GLI APPETITE

GLI and NutriStyle Inc. have partnered to create a personalized nutrition app for people living with liver disease, diabetes, and other chronic conditions or who want to maintain good liver health. The app will create personalized meal plans to meet the specific requirements set out by GLI nutritional advisors for people with NASH or a general interest in liver health.

Livercentral Logo
Liver Central

Global Liver Institute created Liver Central to equip everyone affected by liver cancer. We know that learning, advocacy, and collaboration empowers us to create change in the exam room, in the community, and beyond. Whether you have just received a liver cancer diagnosis, you are interested in new treatment options or clinical trials, or you’re a clinician looking for current practice guidelines, Liver Central exists to help you find the answers you pursue.

Latest Updates

GLILogo Xl

Media Kit: Preparing for First US Approval of NASH Therapy

Our press kit explains the core facts of the GLI, the Resmetirom launch, and why it’s important (especially to patients) to journalists/reporters/the media in a neat, digestible package.

GLILogo Xl

GLI Commends Repurposed Livmarli’s FDA Approval for Patients over 5 with PFIC

(Washington, D.C. March 14, 2024) –Global Liver Institute (GLI) celebrates a win for rare disease patients with the breaking news of the U.S. FDA’s approval for Mirum Pharmaceuticals’ Livmarli to treat cholestasis pruritus in patients 5 and older that have been diagnosed with progressive familial intrahepatic cholestasis (PFIC), a rare, genetic disorder in which bile builds up in the liver.

GLILogo Xl

FDA’s Approval of Breakthrough NASH Treatment Opens Door for a Long-Neglected Patient Population

Today, Global Liver Institute (GLI) recognizes the importance of the first approval by the U.S. Food and Drug Administration (FDA) of a medication for nonalcoholic steatosis (NASH). Developed by Madrigal Pharmaceuticals, Rezdiffra™ (resmetirom) was approved for the treatment of adults with noncirrhotic NASH with moderate to advanced liver fibrosis, in conjunction with diet and exercise.